(Q61975387)

English

Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase III Study to Access the Efficacy and Safety of SP2086 Treated Type 2 Diabetes Patients (English)
0 references
December 2012
0 references
January 2014
0 references
450
0 references
18 year
0 references
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit